Cyclooxygenase and lipoxygenase inhibitors in cancer therapy.
about
White tea extract induces apoptosis in non-small cell lung cancer cells: the role of peroxisome proliferator-activated receptor-{gamma} and 15-lipoxygenasesInhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cellsStress-responsive JNK mitogen-activated protein kinase mediates aspirin-induced suppression of B16 melanoma cellular proliferationCOX-inhibitors relieve the immunosuppressive effect of tumor cells and improve functions of immune effectorsReduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control studyCytochrome p450 epoxygenase metabolism of arachidonic acid inhibits apoptosisThe role of cyclooxygenase and lipoxygenase in cancer chemoprevention.Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation.Chemopreventive effect of montelukast in n-nitroso n-methyl urea induced mammary carcinogenesis in female Sprague-Dawley rats.Topical chemoprevention of skin cancer in mice, using combined inhibitors of 5-lipoxygenase and cyclo-oxygenase-2.Mitochondria are direct targets of the lipoxygenase inhibitor MK886. A strategy for cell killing by combined treatment with MK886 and cyclooxygenase inhibitors.Anti-proliferative effects of lichen-derived inhibitors of 5-lipoxygenase on malignant cell-lines and mitogen-stimulated lymphocytes.Cytotoxic effect of HIV-1 coat glycoprotein gp120 on human neuroblastoma CHP100 cells involves activation of the arachidonate cascade.In vitro proliferation of fibrosarcoma cells depends on intact functions of lipoxygenases and cytochrome P-450-monooxygenase.Lipoxygenase pathway receptor expression in ovarian cancer.Cerium Oxide Nanoparticles Re-establish Cell Integrity Checkpoints and Apoptosis Competence in Irradiated HaCat Cells via Novel Redox-Independent Activity
P2860
Q24618321-F7A241B5-A455-4BA9-AD0F-442325582715Q24643373-7FAD6C0E-F090-4E94-9FC3-AFCD2F7DE715Q28195631-0BD03E39-538A-4C39-9AE6-CAE5C4A8B9F9Q28199336-10467FBA-E89A-402E-8D88-F19DA00BCAF5Q28217572-8901EC8E-A97F-4152-9D2E-23D4813B75D5Q33182344-7F6A8F41-6D1F-45F2-8D60-E4344605704DQ34153217-60477D69-4546-4A8F-9DBF-FE0B32C0F93CQ36646456-F71E01EE-501E-42D4-97F2-6AC220F92AF5Q36965827-578E202E-BBA7-45A8-BA19-0E47B567FEE0Q37272741-7CDF1187-6A01-45F4-BE26-78B1640DEC1BQ40722888-4130BCB1-5C8E-4C74-AFE3-98B8DFA3E7B2Q40866585-61FF7ADF-8DD4-42F7-B261-8368F3652D37Q42990984-370EE737-D0F0-4705-96B8-89BA8AD40293Q44938522-3E255BEF-E02B-4909-95B4-022DDDD2F5E9Q46638059-EE62AC12-9248-4A2B-A7B9-5129C56170B0Q59127988-4FDB39A7-81F0-45A9-A746-2091BF4D79EF
P2860
Cyclooxygenase and lipoxygenase inhibitors in cancer therapy.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Cyclooxygenase and lipoxygenase inhibitors in cancer therapy.
@en
type
label
Cyclooxygenase and lipoxygenase inhibitors in cancer therapy.
@en
prefLabel
Cyclooxygenase and lipoxygenase inhibitors in cancer therapy.
@en
P1476
Cyclooxygenase and lipoxygenase inhibitors in cancer therapy.
@en
P2093
P356
10.1016/S0952-3278(96)90075-7
P577
1996-01-01T00:00:00Z